Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease

NCT00480701 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Parkinson Disease

Interventions

DRUG: [123I]-IBVM

Sponsor

Institute for Neurodegenerative Disorders